Monthly Archives: April 2016
HuMurine Technologies Awarded $299,956 Grant from the National Cancer Institute to Evaluate Immunotherapies in “Humanized” Immune System Mice.
Sacramento, CA (PRWEB) April 12, 2016. HuMurine Technologies today announced that it has been awarded a SBIR Phase I grant by the National Cancer Institute (NCI) for evaluation of novel immuno-modulatory compounds against patient-derived xenografts (PDX) using “humanized” immune system mice (Hu-M™ mouse).....
April 13, 2016